Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cilia and flagella-associated protein 54 (CFAP54) is a central component of the C1d projection in the central microtubule apparatus of motile cilia and flagella[1][2][3][4]. CFAP54 is essential for the correct assembly and function of motile cilia and flagella in mammals. Deficiency or dysfunction of CFAP54 results in primary ciliary dyskinesia (PCD), a syndrome characterized by impaired mucociliary clearance (leading to mucus accumulation), hydrocephalus due to defective cerebrospinal fluid movement, and male infertility caused by abnormal spermatogenesis and defective sperm flagella. CFAP54 acts as a structural and regulatory protein within the C1d complex, which is needed for proper ciliary beat frequency and coordination; loss of CFAP54 causes a structural defect in the C1d projection, leading to decreased ciliary motility and disorganized flagellar assembly[1][2][3][4]. CFAP54 is not currently described as a therapeutic target, nor are there known drugs or small molecules modulating its function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cilia and flagella-associated protein 54 (CFAP54).